Results 111 to 120 of about 8,155 (200)

Long-term outcomes of Graves' disease in children and adolescents receiving antithyroid drugs. [PDF]

Ann Pediatr Endocrinol Metab, 2021
Rho JG, Kum CD, Seo YJ, Shim YS, Lee HS, Hwang JS.   +5 more
europepmc   +1 more source

Rethinking antithyroid drugs in pregnancy [PDF]

Uncontrolled hyperthyroidism in pregnancy poses a risk to both mother and foetus, and the optimal treatment strategy in this setting remains elusive. Instigation of pharmacological therapy or an alternative intervention during pregnancy requires careful ...
Napier C, Pearce SHS
core  

The use of antithyroid drugs should be reduced as much as possible in the first trimester. [PDF]

, 2014
The treatment of choice for hyperthyroidism in pregnancy is antithyroid drugs, but the potential risk of birth defects is of major concern. For the use of thiamazole and carbimazole, there is consistent evidence of an increased risk of birth defects ...
Laurberg, Peter, Andersen, Stine Linding; id_orcid   +1 more
core  

Audit of long-term treatment outcomes of thyrotoxicosis in a single-centre virtual clinic: The utility of long-term antithyroid drugs. [PDF]

Clin Endocrinol (Oxf), 2022
Levy MJ, Reddy N, Price D, Bhake R, Bremner E, Barrowcliffe M, Kieffer V, Robinson C, Zaccardi F, Howlett TA.   +9 more
europepmc   +1 more source

Second coordination sphere regulates nanozyme inhibition to assist early drug discovery

Nature Communications
Early drug discovery is a time- and cost-consuming task requiring enzymes. Although nanozymes with metal sites akin to metallocofactors display similar activities, the lack of proximal amino acids hinders them from more adequately mimicking enzymes for ...
Yu Wu, Jian Li, Wenxuan Jiang, Weiqing Xu, Lirong Zheng, Canglong Wang, Wenling Gu, Chengzhou Zhu   +7 more
doaj   +1 more source

Individualized Graves' disease remission rates conversations: a videographic analysis of medical encounters. [PDF]

Endocrine, 2022
Hidalgo J, Vallejo S, El Kawkgi OM, Ospina NMS, Maraka S, Brito JP.   +5 more
europepmc   +1 more source

Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates. [PDF]

Eur Thyroid J, 2021
Iwaki H, Ohba K, Okada E, Murakoshi T, Kashiwabara Y, Hayashi C, Matsushita A, Sasaki S, Suda T, Oki Y, Gemma R.   +10 more
europepmc   +1 more source

Therapeutic efficacy of glucocorticoids, ATP, and antithyroid drugs in acute thyrotoxic myopathy: evaluation using the acute thyrotoxic myopathy symptom score. [PDF]

Front Endocrinol (Lausanne)
Li Q, Chen X, Huang Z, Zhang Y, Kuang Y, Wu C, Fu S, Wang T, Liu Y, Huang Z, Yang H, Xian J, Li L, Zhou J, Liang X, Qin Y, Luo Z.   +16 more
europepmc   +1 more source

Efficacy of radioactive iodine therapy with concomitant antithyroid drugs in Japanese patients with Graves' disease: a retrospective observational study. [PDF]

BMC Res Notes
Osaki Y, Matsuda E, Fukazawa H, Nakajima R, Matsuda T, Murayama Y, Sugano Y, Iwasaki H, Sekiya M, Shimano H.   +9 more
europepmc   +1 more source

Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs. [PDF]

Medicine (Baltimore), 2020
Cheng Y, Sun Z, Zhong D, Ren L, Yang H.
europepmc   +1 more source